Dexcom (DXCM) Change in Cash (2010 - 2026)

Dexcom (DXCM) has 17 years of Change in Cash data on file, last reported at $199.3 million in Q1 2026.

• Change in Cash for Q1 2026 came in at $199.3 million, down 33.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $212.3 million (up 295.34% YoY), and the FY2025 annual result was $311.8 million, up 683.42% from the prior year.
• Change in Cash improved to $199.3 million in Q1 2026 per DXCM's latest filing, from -$917.8 million in the prior quarter.
• Over five years, Change in Cash peaked at $676.6 million in Q3 2025 and troughed at -$917.8 million in Q4 2025.
• A 5-year average of $3.8 million and a median of -$15.1 million in 2024 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2023 and 2025: Change in Cash jumped 2862.18% in 2023, then plunged 5978.15% in 2025.
• A 5-year view of Change in Cash shows it stood at -$55.8 million in 2022, then slumped by 38.53% to -$77.3 million in 2023, then jumped by 80.47% to -$15.1 million in 2024, then sank by 5978.15% to -$917.8 million in 2025, then surged by 121.71% to $199.3 million in 2026.
• Business Quant data shows DXCM's Change in Cash at $199.3 million in Q1 2026, -$917.8 million in Q4 2025, and $676.6 million in Q3 2025.